Recent Articles from GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Vistagen Therapeutics, Inc. Stockholders of the Upcoming Class Action Lead Plaintiff Deadline and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Vistagen (VTGN) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · January 30, 2026
FISERV INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Fiserv, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Fiserv (FISV) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · January 30, 2026
Dr. Christina Rahm and Clayton Thomas of The ROOT Brands Attend World Economic Forum Annual Meeting 2026 in Davos
Dr. Rahm and Clayton Thomas Join Global Innovators Shaping the Future of Health, Technology, and Human Potential
By The ROOT Brands · Via GlobeNewswire · January 30, 2026
Details on the timetable of the simplified tender offer on North Atlantic Energies shares
Paris, Jan. 30, 2026 (GLOBE NEWSWIRE) -- NORTH ATLANTIC ENERGIES
By North Atlantic · Via GlobeNewswire · January 30, 2026
Dr. Linette Williamson Expands Integrative Medicine Services in Encinitas With Physician-Supervised Ozone Sauna Therapy
Encinitas, CA, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Dr. Linette Williamson, MD, a physician with extensive experience in emergency medicine and integrative functional care, is expanding the therapeutic services offered at her Encinitas-based integrative medical practice with the addition of physician-supervised ozone sauna therapy.
By Linette Williamson MD Inc. · Via GlobeNewswire · January 30, 2026
Transaction in Own Shares
Transaction in Own Shares   
By Shell plc · Via GlobeNewswire · January 30, 2026
Deshaies Electrical Announces EV Charger Installation Services to Support Growing Electric Vehicle Adoption in Maryland
Crofton, MD, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Deshaies Electrical Services, a licensed electrical contractor serving Anne Arundel County and surrounding communities, has announced its residential EV charger installation service to help Maryland homeowners seeking more cost-effective and reliable ways to charge electric vehicles at home. The company has increased its service capacity and homeowner support resources to meet growing customer demand as Maryland continues moving toward wider adoption of EVs.
By Deshaies Electrical Services · Via GlobeNewswire · January 30, 2026
BATH & BODY WORKS CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Bath & Body Works, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Bath & Body Works (BBWI) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · January 30, 2026
Hubbell Incorporated Reports Regular Quarterly Dividend
Shelton, CT, Jan. 30, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Hubbell Incorporated (NYSE:HUBB) today declared a regular quarterly dividend of $1.42 per share on the Company’s common stock. The dividend will be paid on March 16, 2026 to shareholders of record on February 27, 2026.
By Hubbell Inc. · Via GlobeNewswire · January 30, 2026
Garrett Motion Stays in the Fast Lane with Scuderia Ferrari HP
PLYMOUTH, Mich. and ROLLE, Switzerland, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Garrett Motion Inc. (Nasdaq: GTX), a global leader in high-performance turbocharging and electrification technologies, today announced the renewal of its long-standing technical partnership with Scuderia Ferrari HP. Under this extended agreement, Garrett will continue to develop and supply the next-generation turbo system for Ferrari’s Formula 1 power unit starting with the 2026 FIA regulation cycle.
By Garrett Motion Inc. · Via GlobeNewswire · January 30, 2026
Levy Elevated to Managing Partner
He Becomes the Firm's 7th in Its 75-plus Year History
By Rivkin Radler LLP · Via GlobeNewswire · January 30, 2026
MiddleGround Capital Sells Vytl Controls Group
LEXINGTON, Ky., Jan. 30, 2026 (GLOBE NEWSWIRE) -- MiddleGround Capital (“MiddleGround”), an operationally focused private equity firm that makes control investments in North American and European headquartered middle-market B2B industrial and specialty distribution companies, is pleased to announce that it has completed the sale of its portfolio company Vytl Controls Group (“Vytl”), previously known as PVI Holdings, Inc., to an affiliate of SunSource, a value-added industrial distributor and solutions provider with established positions in fluid power, fluid process, fluid conveyance and industrial automation components and systems in the U.S. and Canada.
By MiddleGround Capital · Via GlobeNewswire · January 30, 2026
Bragar Eagel & Squire, P.C. Urges Smart Digital Investors with Large Losses to Contact the Firm Before March 16th
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Smart Digital (SDM) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · January 30, 2026
OKYO Pharma Announces Acceptance of Urcosimod Phase 2 Study Results for Presentation at Prestigious ASCRS Annual Meeting
LONDON and NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announces that an abstract on its lead candidate, urcosimod (formerly OK-101), has been accepted for presentation at the prestigious 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting.
By OKYO Pharma LTD · Via GlobeNewswire · January 30, 2026
Bay Area Delivers a Cheaper Football Championship Weekend Than New Orleans, KAYAK Finds
Flights, hotels, and rental cars for football’s biggest weekend cost significantly less than in last year’s host city
By KAYAK · Via GlobeNewswire · January 30, 2026
CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated
NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
By Bernstein Liebhard LLP · Via GlobeNewswire · January 30, 2026
Demand for Transportation, Skilled Trade and Healthcare Professionals Projected to Continue in 2026
U.S. Department of Labor expects millions of positions to become available nationwide over the next decade.
By Lincoln Tech · Via GlobeNewswire · January 30, 2026
Russian Sandworm group attacks energy company in Poland with DynoWiper, ESET Research discovers
BRATISLAVA, Slovakia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- ESET researchers identified new data-wiping malware that they named DynoWiper, used against an energy company in Poland. The tactics, techniques, and procedures (TTPs) observed during the DynoWiper incident closely resembles the previous one involving the ZOV wiper in Ukraine: Z, O, and V are Russian military symbols. ESET Research attributes DynoWiper to Russia-aligned threat group Sandworm with medium confidence.
By ESET · Via GlobeNewswire · January 30, 2026
Plug to Hold February 2, 2026 Investor Question-and-Answer Forum Ahead of Adjourned Special Meeting
SLINGERLANDS, N.Y., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG) will host an investor question-and-answer discussion on Monday, February 2, 2026 to provide all stockholders with an opportunity to ask questions regarding the proposals to be voted on at the Company’s adjourned Special Meeting of Stockholders on Thursday, February 5, 2026 at 10:00 a.m. ET. At the Special Meeting, Proposals 1 and 2 require the affirmative vote of a majority of the Company’s outstanding shares. The meeting was adjourned to provide stockholders additional time to vote and to facilitate broader participation.
By Plug Power, Inc. · Via GlobeNewswire · January 30, 2026
Voting Rights and Capital
Total Voting Rights
By Shell plc · Via GlobeNewswire · January 30, 2026
Global Virus Network Statement on Nipah Virus Outbreak
TAMPA, Fla., Jan. 30, 2026 (GLOBE NEWSWIRE) -- The Global Virus Network (GVN), representing eminent human and animal virologists from more than 90 Centers of Excellence and Affiliates in over 40 countries dedicated to advancing research, collaboration, and pandemic preparedness, is monitoring reports of a Nipah virus outbreak in India and emphasizes that such cases, while very concerning and serious, are not unexpected or unprecedented. Sporadic Nipah virus infections have occurred almost annually in parts of South Asia, particularly in India and Bangladesh, and do not indicate a new or escalating global threat.
By Global Virus Network · Via GlobeNewswire · January 30, 2026
Mia Syn Shares Tips to Forming Healthy Habits That Last with YourUpdateTV
Registered Dietitian and Nutritionist, Mia Syn, Explains How Small, Science-Backed Changes Can Help People Keep Their Health on Track
By D S Simon · Via GlobeNewswire · January 30, 2026
ABC: Tariffs Drive Construction Materials Prices Up 2.8% in 2025
WASHINGTON, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Construction input prices decreased 0.6% in December compared to the previous month, according to an Associated Builders and Contractors analysis of U.S. Bureau of Labor Statistics’ Producer Price Index data released today. Nonresidential construction input prices decreased 0.7% for the month.
David Ebrahimzadeh and Corniche Capital Lead AI Data Center Investment Strategy Reshaping Commercial Real Estate
NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) -- David Ebrahimzadeh, President of Corniche Capital, today announced an expanded investment thesis centered on AI-driven data centers and digital infrastructure assets, reinforcing Corniche Capital’s role in the evolution of modern commercial real estate.
By Corniche Capital · Via GlobeNewswire · January 30, 2026
Skyscanner Shares the 10 Cheapest Destinations for 2026 with YourUpdateTV
Expert from Skyscanner, Lourdes Losada, Discusses the Cheapest Travel Destinations for 2026 and Tips to Plan Your Next Trip
By D S Simon · Via GlobeNewswire · January 30, 2026
$1 Trillion Defense Surge: Record Aftermarket Demand and AI Tech Integration
Issued on behalf of VisionWave Holdings, Inc.
By USA News Group · Via GlobeNewswire · January 30, 2026
Minuteman Press International Launches Personalize it! Print-on-Demand Program; Earns #1 Entrepreneur Ranking in Printing & Marketing Services Category
Minuteman Press International Is the #1 Ranked Printing & Marketing Services Franchise by Entrepreneur in 2026, Marking 35 Times and 23 Years in a Row
By Minuteman Press International · Via GlobeNewswire · January 30, 2026
Zaya Younan Enters Renewable Energy with One of California’s Largest Solar + Storage Power Plants
Los Angeles, CA, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Visionary entrepreneur and global business leader Zaya Younan, Founder and Chairman of Younan Company, today announced his strategic entry into large-scale renewable energy construction through the launch of a landmark utility-scale solar and battery storage project in California. The initiative positions Younan among the few diversified global executives simultaneously leading major ventures in commercial real estate, luxury hospitality, golf and leisure, fine wines and spirits, premium tobacco and cigars, and now advanced clean-energy infrastructure.
By Younan Properties · Via GlobeNewswire · January 30, 2026
CallRevu Elevates Dealership Communications with DylanAI, a Major Phone System Upgrade as a New Level of AI Receptionist for Automotive
NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) -- CallRevu, the industry-leading communication platform and largest call tracking provider in North America with the only auto-specific phone system, reaches a new level of innovation with the upcoming launch of DylanAI — an AI-powered receptionist redefining dealership IVR’s in how they manage inbound and outbound calls.
By CallRevu · Via GlobeNewswire · January 30, 2026
S. Penny Windle Kline Joins SEDA as Senior Advisor and Board Member, Bringing Over Two Decades of Experience in Complex Litigation and Regulatory Investigations
SEDA Experts LLC, a leading expert witness firm providing world-class financial expert witness services, announced today that S. Penny Windle Kline joined the firm as Senior Advisor and Member of the Board.
By SEDA EXPERTS · Via GlobeNewswire · January 30, 2026
NordVPN’s Threat Protection Pro™ ranks fourth in an independent anti-phishing test
Threat Protection Pro™ achieves 92% detection rate with zero false positives
By NordVPN · Via GlobeNewswire · January 30, 2026
Growing Equity From the Ground Up: Equitable Transfer Program Returns for Round 7
Non-GMO Project partners with BIPOC-led businesses to improve access, nourishment, and community resilience
By Non-GMO Project · Via GlobeNewswire · January 30, 2026
ACTFORE Secures Patent for Template Identification and Matching Technology, Transforming Large-Scale Document Analysis in Breach Response
ACTFORE’s latest patented technology redefines how organizations interpret and organize complex document sets following a cyber breach
By Actfore · Via GlobeNewswire · January 30, 2026
Denmark Moves to Recognize Gastronomy as an Art Form
Today, at the international gastronomy symposium Convergence in Copenhagen, Denmark’s Minister of Culture, Jakob Engel-Schmidt, announced that the Ministry of Culture will examine whether gastronomy can be formally recognized as an art form. The initiative signals a potential shift in Danish cultural policy and a broader understanding of gastronomy as a cultural and artistic discipline. The announcement, made before leading international chefs and more than 1,200 guests, highlights Denmark’s role as a global hub for culinary innovation. "Home to the New Nordic Food Manifesto, world-renowned restaurants, and the highest number of Michelin stars in the Nordic region, Denmark continues to strengthen its position as a leading destination for culinary travel and cultural experiences", says Katja Moesgaard, CEO at VisitDenmark.
By VISITDENMARK · Via GlobeNewswire · January 30, 2026
“Tele-flora” Inspires Americans to Leave Nothing Unsaid with New Valentine’s Day Campaign
LOS ANGELES, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Teleflora®, the world’s leading floral delivery service, is proud to debut its new 2026 Valentine’s Day bouquet lineup alongside a brand-new campaign, “Tele-flora,” inspired by the belief that love often begins with the courage to speak from the heart.
By Teleflora · Via GlobeNewswire · January 30, 2026
RenX Enterprises Expands Contracted Inbound Volumes, Advancing Biomass Processing Platform
Miami, FL, Jan. 30, 2026 (GLOBE NEWSWIRE) -- RenX Enterprises Corp. (NASDAQ: RENX) (“RenX” or the “Company”) (NASDAQ: RENX) (“RenX” or the “Company”) a sustainable infrastructure and environmental services platform, today announced that its operating subsidiary, Resource Group US LLC (“RGUS”), has entered into a new disposal services agreement with a regional commercial landscaping operator serving the Sarasota, Florida market.
By RenX Enterprises Corp. · Via GlobeNewswire · January 30, 2026
Gainwell Convenes State, Provider, and Policy Leaders on Strengthening Medicaid Provider Networks
Virtual roundtable shares actionable strategies to ease administrative strain, improve care access, and accelerate system modernization
By Gainwell Technologies LLC · Via GlobeNewswire · January 30, 2026
Robust Growth Expected in Consumer AR Glasses as Shipments Near 30 Million by 2030, Driven by No-Display Designs
NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) -- The augmented reality (AR) smart glasses market is experiencing strong demand and rapid growth across both consumer and enterprise segments, as suppliers continue to introduce newer and more capable devices aimed at mass adoption. According to global technology intelligence firm ABI Research, the consumer segment will remain the largest vertical with consumer AR smart glasses shipments forecast to grow from roughly 850,000 units in 2024 to approximately 32 million units by 2030, representing a compound annual growth rate (CAGR) of 82.9%. This acceleration is largely driven by the rising popularity of no-display smart glasses, which offer lighter, more portable designs suited for extended daily use.
By ABI Research · Via GlobeNewswire · January 30, 2026
Opendoor 4Q25 Financial Open House: Opendoor to Report Fourth Quarter and Full Year 2025 Financial Results on February 19th, 2026
Opendoor continues commitment to transparency with video livestream and shareholder Q&A
By Opendoor Technologies Inc. · Via GlobeNewswire · January 30, 2026
NeOnc Technologies Secures Strategic PIPE Investment led by $10 Million Investment from Cinctive Capital Management
Investment led by Cinctive Co-Founder Richard Schimel underscores institutional confidence in NeOnc’s biotech pipeline
By NeOnc Technologies Holdings, Inc. · Via GlobeNewswire · January 30, 2026
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
TAIZHOU, China, Jan. 30, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company” or “SXTC”),  a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”), today announced that it will effect a share consolidation of its ordinary shares at a ratio of 1-for-150, effective on February 3, 2026 (the “Share Consolidation”). The Company’s Class A ordinary shares are expected to begin trading on a post-consolidation basis at the open of the market session on February 3, 2026. Upon the market opening on February 3, 2026, the Company’s Class A ordinary shares will continue to be traded on The Nasdaq Stock Market under the symbol “SXTC” with the new CUSIP number G2161P165.
By China SXT Pharmaceuticals, Inc. · Via GlobeNewswire · January 30, 2026
Amplia Therapeutics - Quarterly Activities and Cash Flow Reports - December 2025
Melbourne, Australia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Key Highlights from the Quarter
By Amplia Therapuetics Limited · Via GlobeNewswire · January 30, 2026
ParaZero Secures Second Substantial Order from Major Global Defense Corporation
Kfar Saba, Israel, Jan. 30, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today announced it has received a second substantial order from a major global defense corporation for its advanced interception net-pods.
By ParaZero Technologies Ltd. · Via GlobeNewswire · January 30, 2026
GDS Announces Private Placement of US$300 Million convertible preferred shares to A Chinese Institutional Investor
SHANGHAI, China, Jan. 30, 2026 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced a private placement of US$300 million of Series B convertible preferred shares (the “convertible preferred shares”) to Huatai Capital Investment Limited, a Chinese institutional investor (the “Private Placement”). GDS will use the proceeds from the private placement to fund expansion of its data center capacity and for general corporate purposes.
By GDS Holdings Limited · Via GlobeNewswire · January 30, 2026
Carrier Connect Data Solutions Inc. to Present at the Small Cap Growth Virtual Investor Conference February 5th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · January 30, 2026
Adagio Medical to Present at the Small Cap Growth Virtual Investor Conference February 5th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · January 30, 2026
Global Water Resources Declares Monthly Dividend
PHOENIX, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, has declared under its dividend policy a monthly cash dividend in the amount of $0.02533 per common share (an annual dividend rate of $0.30396 per share).
By Global Water Resources, Inc. · Via GlobeNewswire · January 30, 2026
ALX Oncology Announces Pricing of Underwritten Offering
SOUTH SAN FRANCISCO, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (“ALX Oncology,” Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today announced the pricing of an underwritten offering of common stock and pre-funded warrants. ALX Oncology is selling 76,979,112 shares of common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase 18,574,120 shares of common stock in the offering. The shares of common stock are being sold at an offering price of $1.57 per share, the closing price on January 29, 2026, and the pre-funded warrants are being sold at an offering price of $1.569 per pre-funded warrant, which represents the per share offering price for each share of common stock less the $0.001 per share exercise price for each pre-funded warrant. The gross proceeds to ALX Oncology from this offering are expected to be approximately $150 million, before deducting the underwriting discounts and commissions and other estimated offering expenses, and excluding the exercise of any pre-funded warrants. All shares of common stock and pre-funded warrants to be sold in the offering are being offered by ALX Oncology. The offering is expected to close on or about February 2, 2026, subject to the satisfaction of customary closing conditions.
By ALX Oncology · Via GlobeNewswire · January 30, 2026
Saratoga Investment Corp. Prices Public Offering of $100 Million 7.50% Notes Due 2031
NEW YORK, NY, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Saratoga Investment Corp. (the “Company”) (NYSE: SAR) today announced that it has priced an underwritten public offering of $100.0  million in aggregate principal amount of 7.50% unsecured notes due 2031 (the “Notes”). The offering is subject to customary closing conditions and is expected to close on February 6, 2025.
By Saratoga Investment Corp · Via GlobeNewswire · January 30, 2026
Ultragenyx Resubmits Biologics License Application for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA) to U.S. FDA
Company expects up to six-month review period per FDA guidelines 
By Ultragenyx Pharmaceutical Inc. · Via GlobeNewswire · January 30, 2026
Reliance Global Group Reports 72% Increase in Health Insurance Policies Written Through RELI Exchange During 2025 Open Enrollment
Policy growth reflects strong execution and expanding distribution across RELI Exchange platform
By Reliance Global Group, Inc. · Via GlobeNewswire · January 30, 2026
IperionX – December 2025 Quarterly Report
CHARLOTTE, N.C., Jan. 30, 2026 (GLOBE NEWSWIRE) -- IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) is pleased to present its quarterly report for the period ending December 31, 2025. Highlights during and subsequent to the end of the quarter include:
By IperionX · Via GlobeNewswire · January 30, 2026
Apollo Commercial Real Estate Finance, Inc. Announces Dates for Fourth Quarter and Year End 2025 Earnings Release and Conference Call
NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Apollo Commercial Real Estate Finance, Inc. (the “Company” or “ARI”) (NYSE:ARI), today announced the Company will hold a conference call to review its fourth quarter and full year 2025 financial results on Wednesday, February 11, 2026 at 10:00 a.m. Eastern Time. The Company’s fourth quarter and full year 2025 financial results will be released after the market closes on Tuesday, February 10, 2026. During the conference call, Company officers will review fourth quarter and full year 2025 performance, discuss recent events and conduct a question-and-answer period.
WISeSat.Space Brought Together Global Thought-Leaders to Davos to Address Quantum Security in Space
WISeSat.Space Brought Together Global Thought-Leaders to Davos to Address Quantum Security in Space
Notice To Long-Term Shareholders of Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf
PHILADELPHIA, Jan. 30, 2026 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · January 30, 2026
Obagi Medical and VIO Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
VIO Med Spa selected as a key med spa franchise partner for its commitment to clinical excellence, innovation, and nationwide scalable aesthetic care
By Waldencast plc · Via GlobeNewswire · January 30, 2026
Edible Garden’s Gourmet Greens Hydroponic Basil Now Available at Hannaford
Expanded Distribution Builds on Existing Relationship and Strengthens Regional Retail Presence
By Edible Garden AG Incorporated · Via GlobeNewswire · January 30, 2026
Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (NASDAQ: LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Settles
PHILADELPHIA, Jan. 30, 2026 (GLOBE NEWSWIRE) -- WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Lifecore Biomedical, Inc. (NASDAQ: LFCR) as a securities fraud class action has now reached a settlement. The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
By Grabar Law Office · Via GlobeNewswire · January 30, 2026
New Data Demonstrate CD47 Expression Level Helps Predict Response to ALX Oncology’s Evorpacept in Combination with Ziihera (zanidatamab-hrii) in Advanced HER2-Positive Breast Cancer
- Exploratory analysis from Phase 1b/2 breast cancer trial reinforces CD47 as a predictive biomarker for response, as previously observed in the ASPEN-06 trial in HER2-positive gastric cancer –
By ALX Oncology · Via GlobeNewswire · January 30, 2026
PropQwiz Awards Life-Changing $350,000 Grand Prize to First Winner, a Las Vegas Mother
The Free, Live Daily Mobile Game Challenges Players to Guess Real Home Listing Prices in Order to Win Free Rent or Mortgage 
By PropQwiz · Via GlobeNewswire · January 30, 2026
Polaryx Therapeutics Announces Approval to List Common Stock on Nasdaq
PARAMUS, NJ, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics (“Polaryx” or the “Company”) a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (“LSDs”), today announced that shares of the Company’s common stock have been approved for listing on the Nasdaq Capital Market (“Nasdaq”) under the ticker symbol “PLYX”. Shares of Polaryx common stock are expected to commence trading on or about February 2, 2026.
By Polaryx Therapeutics, Inc. · Via GlobeNewswire · January 30, 2026
Gentex Reports Fourth Quarter And Year End 2025 Financial Results
ZEELAND, Mich., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Gentex Corporation (NASDAQ: GNTX), a leading supplier of digital vision, connected car, dimmable glass, fire protection technologies, medical devices, and consumer electronics, today reported financial results for the fourth quarter and calendar year ended December 31, 2025.
By Gentex Corporation · Via GlobeNewswire · January 30, 2026
Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis
TOKYO and PRINCETON, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), a Japan-based global specialty pharmaceutical company, today announced the termination of the current rocatinlimab development and commercialization collaboration with Amgen. Kyowa Kirin will regain control of the global rocatinlimab program, including regulatory filings and future commercialization. This business decision is the result of a strategic portfolio prioritization by Amgen. The companies are initiating a smooth and orderly transition of the program, with a focus on ensuring continuity for participants currently enrolled in clinical trial programs. Amgen, who has partnered with Kyowa Kirin on numerous investigational therapies over 41 years, will continue to manufacture rocatinlimab.
By Kyowa Kirin · Via GlobeNewswire · January 30, 2026
First Hawaiian, Inc. Reports Fourth Quarter 2025 Financial Results and Declares Dividend
HONOLULU, Jan. 30, 2026 (GLOBE NEWSWIRE) -- First Hawaiian, Inc. (NASDAQ:FHB), (“First Hawaiian” or the “Company”) today reported financial results for its quarter ended December 31, 2025.
By First Hawaiian, Inc. · Via GlobeNewswire · January 30, 2026
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options to purchase an aggregate of 81,100 shares of the Company’s stock (the “Inducement Grant”) to newly hired employees on January 29, 2026 (the “Grant Date”), in connection with the commencement of employment.
By Aligos Therapeutics · Via GlobeNewswire · January 30, 2026
Edible Garden Announces Reverse Stock Split of the Company’s Common Stock
BELVIDERE, NJ, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leading provider of controlled environment agriculture (CEA) solutions and sustainable, locally grown organic produce,  today announced a planned reverse stock split of its shares of common stock at a ratio of 1-for-10. The reverse stock split will take effect as of 12:01 a.m. ET, on February 3, 2026, and shares of Edible Garden will trade on a post-split basis on Nasdaq under the existing trading symbol, “EDBL,” at the market open on February 3, 2026.
By Edible Garden AG Incorporated · Via GlobeNewswire · January 30, 2026
Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy
KUALA LUMPUR, Malaysia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or “Alps Group”), the parent company of Alps Life Sciences Inc. (“Alps Holdco”), a fully integrated biotechnology research and healthcare platform specializing in predictive, preventive, and precision medicine, today announced a potential expansion of its exosome-related pipeline beyond its previously disclosed CELESOME(+) program. The announcement follows the publication of a preliminary retrospective clinical case series in SAGE Open Medical Case Reports describing nebulized human umbilical cord mesenchymal stem cell (“hUCMSC”) derived exosome in patient with asthma and/or chronic obstructive pulmonary disease (“COPD“). The clinical case series study was registered with the National Medical Research Register, Ministry of Health Malaysia (NMRR ID-25-00600-F4A).
By Alps Group Inc · Via GlobeNewswire · January 30, 2026
Westwood Holdings Group, Inc. to Host Fourth Quarter and Fiscal Year 2025 Conference Call/Webcast
DALLAS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Westwood Holdings Group, Inc. (NYSE:WHG) will release its fourth quarter and fiscal year 2025 earnings after the close of the New York Stock Exchange on Friday, February 13, 2026. Following the release, the Company will host a live audio webcast and conference call at 4:30 pm Eastern Time (3:30 pm Central Time).
By Westwood Holdings Group Inc · Via GlobeNewswire · January 30, 2026
Goranson Bain Ausley Welcomes Collaborative Family Law Attorney Jill Lowe to Plano Office
Goranson Bain Ausley, a leading Texas family law firm, announced that Jill Lowe has joined the firm as a family law attorney, bringing more than 21 years of legal experience and a strong focus on collaborative, settlement-focused divorce.
By Goranson Bain Ausley · Via GlobeNewswire · January 30, 2026
CIRM approves new $100 million plan to accelerate genetic therapies for patients with rare diseases
South San Francisco, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- The California Institute for Regenerative Medicine (CIRM) has approved a new funding program to accelerate therapies for rare diseases, which sets aside $100 million over two years to create a scalable model that rapidly delivers transformative, platform-based genetic therapies for the millions of people in the U.S. living with rare diseases. The Rare Disease Acceleration Platform and Innovation and Delivery (RAPID) program builds on the recent success of a genetic therapy developed in six months for Baby KJ, the first infant successfully treated for a rare, life-threatening disorder called CPS1 deficiency.  
Horizon Space Acquisition II Corp. Postponed the Extraordinary General Meeting to February 12, 2026 and Extended the Redemption Request Deadline
New York, NY, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Horizon Space Acquisition II Corp. (the “Company” or “HSPT”) (NASDAQ: HSPT) today announced that it postponed the extraordinary general meeting (the “Extraordinary Meeting”) originally scheduled at 9:00 a.m. Eastern Time, on February 3, 2026, to 9:00 a.m. Eastern Time, on February 12, 2026 (the “Postponement”) to allow the Company additional time to engage with its shareholders.
ProMIS Neurosciences Announces Up to $175 Million Private Placement Financing
Extends cash runway into 2028
By ProMIS Neurosciences Inc. · Via GlobeNewswire · January 30, 2026
Centerra Gold Reports Explosion at Langeloth; No Fatalities or Significant Environmental Releases
TORONTO, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Centerra Gold Inc. (“Centerra” or the “Company”) (TSX: CG) (NYSE: CGAU) has suspended operations at its Langeloth Metallurgical Facility (“Langeloth”) near Pittsburgh, Pennsylvania following an explosion on January 29, 2026 at approximately 6:15 p.m. Eastern Time, which was a result of an uncontrolled mixture of chemicals leading to an uncontained chemical reaction adjacent to the acid plant. No fatalities were reported, but two contractors were taken to hospital with injuries, and two employees were taken to hospital for precautionary reasons. Presently, there is no indication of a significant environmental release. The relevant regulatory agencies and authorities have been notified. The Company is currently assessing Langeloth’s estimated downtime and will provide an update when more information is available.
By Centerra Gold Inc · Via GlobeNewswire · January 30, 2026
CN Announces New Normal Course Issuer Bid for Share Repurchase and 3% Dividend Increase
MONTREAL, Jan. 30, 2026 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) announced today that its Board of Directors has approved a 3% increase in the 2026 dividend on the Company's outstanding common shares as well as the repurchase of its shares under a new normal course issuer bid (Bid).
By Canadian National Railway Company · Via GlobeNewswire · January 30, 2026
CN Announces Solid Fourth Quarter and Year-End Results
MONTREAL, Jan. 30, 2026 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) today reported its financial and operating results for the fourth quarter and year ended December 31, 2025.
By Canadian National Railway Company · Via GlobeNewswire · January 30, 2026